(Q43667010)

25 November 2017

title

Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients (English)

1 reference

25 November 2017

1 reference

1 reference

Pneumocystis carinii

1 reference

P M Girard

1

1 reference

25 November 2017

R Landman

2

1 reference

25 November 2017

C Gaudebout

3

1 reference

25 November 2017

A Lepretre

4

1 reference

25 November 2017

P Lottin

5

1 reference

25 November 2017

C Michon

6

1 reference

25 November 2017

P De Truchis

7

1 reference

25 November 2017

S Matheron

8

1 reference

25 November 2017

F Camus

9

1 reference

25 November 2017

R Farinotti

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

25 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

25 November 2017

volume

1

1 reference

25 November 2017

issue

8651

1 reference

25 November 2017

page(s)

1348-1353

1 reference

Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Diabetes mellitus following pentamidine-induced hypoglycemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Differences in relative efficiency of nebulisers for pentamidine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Spontaneous pneumothoraces in AIDS patients receiving aerosolized pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Aerosol deposition considerations in inhalation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Ultrasonic nebulised pentamidine for pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992802-X

1 reference

7 January 2021

10.1016/S0140-6736(89)92802-X

Identifiers

DOI

1 reference

25 November 2017

1 reference